August 2002: The Best From Barcelona
August 2002: The Best From Barcelona
The biannual International AIDS Conference is always a colorful affair, where individuals working on all aspects of the epidemic and those directly affected by HIV come together to share and debate the latest initiatives in treatment, research, prevention, policy, and social science.
Last month's meeting in Barcelona, Spain, was no exception. Like its predecessor in Durban, South Africa, in 2000, it was dominated by the two-pronged disaster unfolding in the developing world: catastrophic and still rising rates of infection (as documented in a report published by UNAIDS immediately before the conference), combined with little or no access to the medications that have transformed the prospects for many in the West.
For those of us lucky enough to live in countries where antiretrovirals and other medical treatments are available, there was plenty of important news. In our continuing education program for physicians, pharmacists, and nurses, just published, leading experts offer their analysis of data on antiretroviral therapy in treatment-naive and -experienced patients, the intriguing findings that cast new doubts over our understanding of lipodystrophy, and research into the management of opportunistic diseases and coinfections. Also, be sure not to miss the additional 20 news reports written by our expert faculty during the meeting focusing on individual studies, and over 40 news reports from Medscape Medical News and other sources.
Conference coverage is one of the most popular features on Medscape, and to meet that interest we are planning coverage of several more HIV meetings this year. In addition to our just-published authoritative review of the XI International HIV Drug Resistance Workshop by Daniel R. Kuritzkes, MD, we will soon post coverage of the 6th International Conference on Malignancies in AIDS & Other Immunodeficiencies, in association with our partners at the National Cancer Institute. Also, this Fall our expert authors will be reporting from the following conferences:
You can plan your own conference attendance using our calendar of all the major HIV-related meetings.
As always, we welcome your feedback. Please let me know how we are doing, what new features we might offer, and how we might make the site work better for you. You can email me directly at HIVeditor@webmd.net, and I'll reply to every message. (If your concern is technical, however, please contact our customer support staff at medscapecustomersupport@webmd.net).
The biannual International AIDS Conference is always a colorful affair, where individuals working on all aspects of the epidemic and those directly affected by HIV come together to share and debate the latest initiatives in treatment, research, prevention, policy, and social science.
Last month's meeting in Barcelona, Spain, was no exception. Like its predecessor in Durban, South Africa, in 2000, it was dominated by the two-pronged disaster unfolding in the developing world: catastrophic and still rising rates of infection (as documented in a report published by UNAIDS immediately before the conference), combined with little or no access to the medications that have transformed the prospects for many in the West.
For those of us lucky enough to live in countries where antiretrovirals and other medical treatments are available, there was plenty of important news. In our continuing education program for physicians, pharmacists, and nurses, just published, leading experts offer their analysis of data on antiretroviral therapy in treatment-naive and -experienced patients, the intriguing findings that cast new doubts over our understanding of lipodystrophy, and research into the management of opportunistic diseases and coinfections. Also, be sure not to miss the additional 20 news reports written by our expert faculty during the meeting focusing on individual studies, and over 40 news reports from Medscape Medical News and other sources.
Conference coverage is one of the most popular features on Medscape, and to meet that interest we are planning coverage of several more HIV meetings this year. In addition to our just-published authoritative review of the XI International HIV Drug Resistance Workshop by Daniel R. Kuritzkes, MD, we will soon post coverage of the 6th International Conference on Malignancies in AIDS & Other Immunodeficiencies, in association with our partners at the National Cancer Institute. Also, this Fall our expert authors will be reporting from the following conferences:
2nd International HIV Workshop on Management of Treatment-Experienced Patients
4th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV
42nd Interscience Conference on Antimicrobial Agents and Chemotherapy
40th Annual Meeting of the Infectious Diseases Society of America
6th International Congress on Drug Therapy in HIV Infection
You can plan your own conference attendance using our calendar of all the major HIV-related meetings.
As always, we welcome your feedback. Please let me know how we are doing, what new features we might offer, and how we might make the site work better for you. You can email me directly at HIVeditor@webmd.net, and I'll reply to every message. (If your concern is technical, however, please contact our customer support staff at medscapecustomersupport@webmd.net).
Source...